Genetic Counseling of Asymptomatic Carriers in a Primary Care Setting
The Effectiveness of Screening and Counseling for Beta-Thalassemia Trait
- MACK LIPKIN, Jr., M.D.;
- LAWRENCE FISHER, Ph.D.;
- PETER T. ROWLEY, M.D.;
- STARLENE LOADER, B.A.; and
- HOWARD P. IKER, Ph.D.
Abstract
In a prospective, controlled, stratified, experimental effectiveness study of screening and counseling, 25 000 consecutive adults were screened for thalassemia trait. Eight hundred forty-three adults had a mean corpuscular volume less than 77 fL; 192 (22% of those with microcytosis) had hemoglobin A2 greater than 3.5%, proving beta-thalassemia trait. Video-program, neutral-educational, and patient-centered counseling methods produced equal levels of learning, retention, psychologic impact, and effects on life adjustment immediately and at 2 and 10 months after counseling. Ninety-nine percent of the patients told other persons about the counseling, and 43% had 106 others screened. Factors related to having someone else screened included plans to have children (p < 0.002), being younger (p < 0.0025), better education (p < 0.05), and having high knowledge of thalassemia (p = 0.05). For maximum effectiveness, screening and counseling programs should focus on patients for whom a positive result has high significance.
Article and Author Information
-
▸From the Departments of Medicine and Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, and the Department of Medicine, New York University School of Medicine, New York, New York; and the Department of Psychiatry, University of California, San Francisco, Fresno, California.
-
Grant support: in part by grant R01-HL-17465 from the National Institutes of Health; New York State Health Research Council Grants 146 and 664; and the Rockefeller Foundation.
-
▸Requests for reprints should be addressed to Mack Lipkin, Jr., M.D.; Department of Medicine, NYU Medical Center, 550 First Avenue; New York, NY 10016.
- © 1986 American College of Physicians
RSS Feeds









